Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
Long-Term Investments
Aurinia Pharmaceuticals Inc
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Long-Term Investments
$199k
|
CAGR 3-Years
-75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Long-Term Investments
$82.1m
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Long-Term Investments
$13.7m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Long-Term Investments
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aurinia Pharmaceuticals Inc's Long-Term Investments?
Long-Term Investments
199k
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Long-Term Investments amounts to 199k USD.
What is Aurinia Pharmaceuticals Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-75%
The average annual Long-Term Investments growth rates for Aurinia Pharmaceuticals Inc have been -75% over the past three years .